Vocal fold leukoplakia recurrence risk model

被引:0
作者
Hanna Klimza
Joanna Jackowska
Wioletta Pietruszewska
Andrzej Porębski
Piotr Nogal
Agata Leduchowska
Małgorzata Wierzbicka
机构
[1] Research & Development Centre,Regional Specialist Hospital Wroclaw
[2] Wroclaw University of Science and Technology,Department of Otolaryngology, Head and Neck Surgery
[3] Institute of Human Genetics Polish Academy of Sciences,Department of Otiatrics, Laryngology and Laryngological Oncology
[4] Poznań University of Medical Sciences,Faculty of Law and Administration
[5] Medical University of Łódź,undefined
[6] Jagiellonian University,undefined
来源
Scientific Reports | / 14卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The paper aims to define the variables that elevate the risk of VFL recurrence after adequate primary treatment, and to present the Recurrence Risk Model with practical conclusions to handle pVFL and rVFL. Out of 207 patients with primary vocal fold leukoplakia (pVFL), in 41 (19.8%) recurrent VFL (rVFL) was diagnosed. All patients were assessed by using a trans-nasal flexible video-endoscope using white light, and NBI. The primary measure of our study was to investigate whether morphological features of pVFL in WL, vascular pattern in NBI, and primary histological findings could predict VFL recurrence. To create a model of risk factors, two methods were used: logistic regression and a conditional inference decision tree. The study showed smoking was the factor that significantly and most strongly increased the likelihood of rVFL, as well as the older age groups have a greater odds of rVFL. Types IV, V and VI, according to Ni 2019 classification, were associated with a significantly higher risk of rVFL. The algorithm combining patients’ dependent variables and the combination of two classifications improves the predictive value of the presented VFL Recurrence Risk Model.
引用
收藏
相关论文
共 123 条
[1]  
Isenberg JS(2008)Institutional and comprehensive review of laryngeal leukoplakia Ann. Otol. Rhinol. Laryngol. 117 74-79
[2]  
Crozier DL(1991)Laryngeal precancer: A review of the literature, commentary, and comparison with oral leukoplakia Head Neck 13 488-497
[3]  
Dailey SH(2013)Clinical classification and treatment of leukokeratosis of the vocal cords Chin. Med. J. 126 3523-3527
[4]  
Bouquot JE(2013)Management of premalignant lesions of the larynx Expert Rev. Anticancer Ther. 13 1045-1051
[5]  
Gnepp DR(2006)World Health Organization classification of tumours: Pathology and genetics of head and neck tumours Ear Nose Throat J. 85 74-74
[6]  
Ma L(2010)Consensus statement by otorhinolaryngologists and pathologists on the diagnosis and management of laryngeal dysplasia Clin. Otolaryngol. 35 170-176
[7]  
Wang J(2021)Vocal fold leukoplakia: Which of the classifications of white light and narrow band imaging most accurately predicts laryngeal cancer transformation? Proposition for a diagnostic algorithm Cancers 13 3273-3435
[8]  
Xiao Y(2017)Recurrence of vocal fold leukoplakia after carbon dioxide laser therapy Eur. Arch. Oto-Rhino-Laryngol. 274 3429-27
[9]  
Ye J(2016)Treatment outcome of vocal cord leukoplakia by transoral laser microsurgery Lasers Med. Sci. 32 19-596
[10]  
Xu W(2019)A morphological classification for vocal fold leukoplakia Braz. J. Otorhinolaryngol. 85 588-434